Pancreatic Cancer Trial, Recruiting (NCT06291324)

Pancreatic Cancer Trial, Recruiting NCT06291324 Sponsor: Wake Forest University Health Sciences Condition: Pancreatic Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06291324 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pancreatic Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have pancreatic cancer or invasive breast cancer, and who are planning to start or have already started cancer treatment
People who report experiencing fatigue at any level
People aged 18 or older at the time of signing consent
People who are able to read and understand English
People who are able to follow study procedures for the full length of the study, such as completing questionnaires and returning a study device
People who agree to sign a consent form and allow their personal health information to be used for the study

Who may not be able to join:

People with a significant heart-related condition that the enrolling doctor determines could affect the study results
People where the enrolling doctor determines that taking part would not be in their best interest, or where participation could interfere with study results or prevent the study from being completed
People who do not have access to the internet, Wi-Fi, or an email account
People who do not have access to a smartphone or mobile device

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Dori Beeler, PhD, Wake Forest University Health Sciences

Phone: 704-754-3768

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06291324

Sponsor: Wake Forest University Health Sciences

Phase: Not Applicable

Status: Recruiting

Condition: Pancreatic Cancer

Trial contact: 704-754-3768

More information: https://clinicaltrials.gov/study/NCT06291324

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have pancreatic cancer or invasive breast cancer, and who are planning to start or have already started cancer treatment
People who report experiencing fatigue at any level
People aged 18 or older at the time of signing consent
People who are able to read and understand English
People who are able to follow study procedures for the full length of the study, such as completing questionnaires and returning a study device
People who agree to sign a consent form and allow their personal health information to be used for the study

Who may not be able to join:

People with a significant heart-related condition that the enrolling doctor determines could affect the study results
People where the enrolling doctor determines that taking part would not be in their best interest, or where participation could interfere with study results or prevent the study from being completed
People who do not have access to the internet, Wi-Fi, or an email account
People who do not have access to a smartphone or mobile device

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Wake Forest University Health Sciences

Registry

ClinicalTrials.gov

Start date

4 October 2024

Est. completion

30 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Adherence and acceptability

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov